Company: CLX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000021076-25-000053
Chunk: 61

Company: CLOROX CO /DE/
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 61
---
,762 All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.Segment adjusted EBIT, including the significant segment expense provided to the CODM, and a reconciliation to earnings before income taxes for the three months ended September 30:Segment adjusted earnings (losses) before interest and income taxesThree months ended September 30, 2025Health and WellnessHouseholdLifestyleInternationalTotalNet sales$565 $362 $245 $253 Cost of products sold291 246 126 165 Other segment items (1)150 89 81 69 Segment adjusted EBIT$124 $27 $38 $19 $208 Corporate and Other (48)Interest income2 Interest expense(23)Digital capabilities and productivity enhancements investment (2)(32)Earnings before income taxes$107 (1)Other segment items includes selling, general and administrative expenses, advertising costs, research and development costs and other income and expenses. The charges defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other.(2)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.  

16

NOTE 12. SEGMENT RESULTS (Continued)

Segment adjusted earnings (losses) before interest and income taxesThree months ended September 30, 2024Health and WellnessHouseholdLifestyleInternationalTotalNet sales$698 $447 $320 $259 Cost of products sold322 289 157 158 Other segment items (1)141 98 97 66 Segment adjusted EBIT$235 $60 $66 $35 $396 Corporate and Other (64)Interest income3 Interest expense(21)Loss on divestiture (2)(118)Cyberattack costs, net of insurance recoveries (3)10 Digital capabilities and productivity enhancements investment (4)(29)Earnings before income taxes$177 (1)Other segment items includes selling, general and administrative expenses, advertising costs, research and development costs and other income and expenses. The charges defined in segment adjusted EBIT above are excluded from other segment items and Corporate and Other.(2)Represents the loss on divestiture of the Better Health VMS business corresponding to Corporate and Other. See Note 3 for additional details related to the divestiture.(3)Represents insurance recoveries related to the cyberattack corresponding to Corporate